KLRS

Kalaris Therapeutics

84 hedge funds and large institutions have $110M invested in Kalaris Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$129K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$7.8M
2 +$2.94M
3 +$970K
4
BlackRock
BlackRock
New York
+$966K
5
State Street
State Street
Massachusetts
+$566K

Top Sellers

1 -$9.72M
2 -$2.92M
3 -$2.46M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$922K
5
Citadel Advisors
Citadel Advisors
Florida
-$736K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$304K
27
$300K
28
$294K
29
$292K
30
$215K
31
$197K
32
$169K
33
$169K
34
$157K
35
$151K
36
$151K
37
$145K
38
$133K
39
$131K
40
$130K
41
$121K
42
$118K
43
$111K
44
$105K
45
$98K
46
$92K
47
$91K
48
$85K
49
$84K
50
$81K